RAPS Highlights

 

 

 

 

18 August 2022 | By Ferdous Al-Faruque
OIG reprimands NIH for not enforcing trial transparency requirements

The US Department of Health and Human Services (HHS) Office of Inspector General (OIG) says the National Institutes of Health (NIH) ...

18 August 2022 | By Jeff Craven
Euro Roundup: UK committee advises a mix of COVID boosters for autumn

JCVI advised the UK government to adopt Pfizer’s Comirnaty and Moderna’s Spikevax for the autumn booster program in addition to Mode...

18 August 2022 | By Michael Mezher
FDA updates 19-year-old replacement reagent policy for IVDs

The US Food and Drug Administration (FDA) on Tuesday finalized its guidance explaining its policies for replacement reagents and ins...

18 August 2022 | By Michael Mezher
Recon: FDA approves Bluebird’s beta-thalassemia gene therapy; WHO recommends Valneva COVID vaccine

Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.

17 August 2022 | By Ferdous Al-Faruque
FDA drafts guidance to improve hydrogen peroxide-based contact lens care product labeling

The US Food and Drug Administration has developed draft guidance for manufacturers of hydrogen peroxide-based contact lens care prod...